Dr. Lori Schleicher
Claim this profileNewark Beth Israel Medical Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
10 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage II
Stage I
Stage III
2Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Lori Schleicher is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Lori Schleicher
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Lori Schleicher has experience with
- Biospecimen Collection
- Crizotinib
- Trastuzumab
- Pertuzumab
- Cetuximab
- Irinotecan Hydrochloride
Breakdown of trials Lori Schleicher has run
Non-Small Cell Lung Cancer
Cancer
ALK Gene Rearrangement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lori Schleicher specialize in?
Lori Schleicher focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Lori Schleicher currently recruiting for clinical trials?
Yes, Lori Schleicher is currently recruiting for 2 clinical trials in Newark New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Lori Schleicher has studied deeply?
Yes, Lori Schleicher has studied treatments such as Biospecimen Collection, Crizotinib, Trastuzumab.
What is the best way to schedule an appointment with Lori Schleicher?
Apply for one of the trials that Lori Schleicher is conducting.
What is the office address of Lori Schleicher?
The office of Lori Schleicher is located at: Newark Beth Israel Medical Center, Newark, New Jersey 07112 United States. This is the address for their practice at the Newark Beth Israel Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.